13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q1 2024. See the latest, Q2 2026 →
Reported value
$493.90B
+11% on the quarter before
Positions
432
20 new · 26 sold out
Top 10
29.5%
of the value
Est. gain
+$44.78B
on stocks held all quarter
Est. return
+10.7%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 46% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amgen Inc~$1.68BAdded · 0.1% → 0.4%+5,923,915 shares
- Ingersoll Rand Inc~$1.32BAdded · 0.2% → 0.5%+13,919,775 shares
- Alphabet~$1.14BAdded · 2.5% → 2.7%+7,470,042 shares
- Charter Communications Inc N~$1.07BAdded · 0.6% → 0.6%+3,685,451 shares
- General Electric Co~$932.0MAdded · 1.5% → 2.1%+5,309,543 shares
- Constellation Brands Inc~$898.1MAdded · 0.5% → 0.6%+3,304,709 shares
- Rexford Indl Rlty Inc~$860.3MAdded · 0.0% → 0.2%+17,103,653 shares
- Merck & Co Inc~$774.0MAdded · 0.0% → 0.2%+5,865,948 shares
- TSMC~$767.9MAdded · 0.3% → 0.5%+5,643,949 shares
- Intel~$683.6MAdded · 1.1% → 1.0%+15,475,631 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$3.09BCut · 5.8% → 5.6%−2,331,902 shares
- Meta~$2.55BCut · 2.8% → 2.9%−5,244,807 shares
- Zoetis Inc~$2.47BCut · 0.6% → 0.0%−14,577,136 shares
- Johnson & Johnson~$1.87BCut · 1.0% → 0.5%−11,829,795 shares
- Karuna Therapeutics Inc~$1.34BSold out · 0.3% → 0.0%−4,227,102 shares
- Netflix~$1.09BCut · 1.0% → 0.9%−1,802,309 shares
- Godaddy Inc~$911.4MCut · 0.3% → 0.1%−7,679,861 shares
- Equinix~$896.4MCut · 0.6% → 0.4%−1,086,078 shares
- Union Pac Corp~$846.6MCut · 0.8% → 0.5%−3,442,404 shares
- Edwards Lifesciences Corp~$652.2MCut · 0.2% → 0.0%−6,824,658 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +1.0% · price +11.9% | 7.1% | $35.16B | +$3.70B | ||||||||
| BroadcomCOM · shares −10.0% · price +18.7% | 5.6% | $27.83B | +$4.39B | ||||||||
| MetaCL A · shares −15% · price +37.2% | 2.9% | $14.32B | +$3.88B | ||||||||
| AlphabetCAP STK CL C · shares +9.3% · price +8.0% | 2.7% | $13.36B | +$909.0M | ||||||||
| General Electric CoCOM NEW · shares +9.9% · price +37.5% | 2.1% | $10.37B | +$2.58B | ||||||||
| MastercardCL A · shares −0.5% · price +12.9% | 2.0% | $10.08B | +$1.15B | ||||||||
| Philip Morris Intl IncCOM · shares −0.01% · price −2.6% | 1.9% | $9.40B | −$252.4M | ||||||||
| Abbvie IncCOM · shares +6.9% · price +17.5% | 1.8% | $8.76B | +$1.22B | ||||||||
| Jpmorgan Chase & CoCOM · shares +1.9% · price +17.8% | 1.7% | $8.47B | +$1.25B | ||||||||
| Transdigm Group IncCOM · shares −0.01% · price +21.7% | 1.6% | $8.09B | +$1.44B | ||||||||
| Abbott LabsCOM · shares +9.1% · price +3.3% | 1.6% | $7.98B | +$230.6M | ||||||||
| AmazonCOM · shares +7.4% · price +18.7% | 1.5% | $7.64B | +$1.12B | ||||||||
| Rtx CorporationCOM · shares +4.8% · price +15.9% | 1.4% | $6.67B | +$873.5M | ||||||||
| Visa Inc.COM CL A · shares +2.7% · price +7.2% | 1.3% | $6.58B | +$429.7M | ||||||||
| AppleCOM · shares +7.1% · price −10.9% | 1.3% | $6.37B | −$730.4M | ||||||||
| Unitedhealth Group IncCOM · shares −3.0% · price −6.0% | 1.2% | $5.69B | −$365.2M | ||||||||
| Northrop Grumman CorpCOM · shares +5.6% · price +2.3% | 1.1% | $5.62B | +$117.4M | ||||||||
| Eli LillyCOM · shares +5.1% · price +33.5% | 1.1% | $5.42B | +$1.29B | ||||||||
| Comcast Corp NewCL A · shares −1.3% · price −1.1% | 1.1% | $5.29B | −$61.3M | ||||||||
| Constellation Energy CorpCOM · shares +2.1% · price +58.1% | 1.1% | $5.26B | +$1.89B | ||||||||
| IntelCOM · shares +16% · price −12.1% | 1.0% | $4.95B | −$587.5M | ||||||||
| Carrier GlobalCOM · shares +4.6% · price +1.2% | 1.00% | $4.93B | +$55.0M | ||||||||
| Linde PlcSHS · shares −2.9% · price +13.1% | 0.98% | $4.85B | +$560.2M | ||||||||
| AlphabetCAP STK CL A · shares −0.6% · price +8.0% | 0.92% | $4.56B | +$339.7M | ||||||||
| Applied MaterialsCOM · shares −0.5% · price +27.2% | 0.91% | $4.51B | +$966.4M | ||||||||
| Total · 432 positions | 100% | $493.90B | +$44.78B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 412 stocks held throughout, up $44.78B (+10.7%).
- Broadcom+$4.39B+19%
- Meta+$3.88B+37%
- Microsoft+$3.70B+12%
- General Electric Co+$2.58B+38%
- Constellation Energy Corp+$1.89B+58%
- Nike Inc−$343.2M−13%
- Unitedhealth Group Inc−$365.2M−6%
- Intel−$587.5M−12%
- Charter Communications Inc N−$674.1M−25%
- Apple−$730.4M−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |